These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33449527)

  • 21. [Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke].
    Kotov SV; Borisova VA; Slyunkova EV; Isakova EV; Kiselev AV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):26-32. PubMed ID: 34932282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical efficacy of neuropeptides in cerebrovascular pathology].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):88-93. PubMed ID: 28635743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].
    Loskutnikov MA; Domashenko MA; Vakin TM; Trushina IA; Konstantinov VI; Proskuryakova OS; Shchukina EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):22-26. PubMed ID: 33244953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cognitive disorders and their correction in patients with ischemic stroke].
    Evzel'man MA; Aleksandrova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10):36-9. PubMed ID: 24300803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of amantadine sulfate in ischemic stroke].
    Ramazanov GR; Kovaleva EA; Shevchenko EV; Akhmatkhanova LK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):56-59. PubMed ID: 33449534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity].
    Nurguzhaev ES; Mitrokhin DA; Izbasarova ASh; Nurguzhaev AE; Raimkulov BN; Abdil'manova BR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):66-9. PubMed ID: 19672239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].
    Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of cellex on cognitive and speech impairments in the acute stage of stroke].
    Kovalenko AV; Safronova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):40-44. PubMed ID: 25909788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency].
    Kurkin DV; Morkovin EI; Kalatanova AV; Bakulin DA; Verholyak DV; Kovalev NS; Dubrovina MA; Tyurenkov IN; Petrov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7):84-89. PubMed ID: 34460162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The biomarkers of cerebral ischemia as a new method for the validation of the efficacy of cytoprotective therapy].
    Dambinova SA; Aliev KT; Bondarenko EV; Ponomarev GV; Skoromets AA; Skoromets AP; Skoromets TA; Smolko DG; Shumilina MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):62-67. PubMed ID: 28638033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The efficacy of the anti-acidemic agent dimephosphone at the first rehabilitation stage in patients in the acute period of carotid-related ischemic stroke].
    Danilova TV; Knni KS; Magsumova RL; Baranova EA; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3):44-51. PubMed ID: 33834717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of recognan in the early stage of ischemic stroke].
    Mashin VV; Belova LA; Dudikov EM; Bergelson TM; Lankov VA; Zakuraeva KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):44-48. PubMed ID: 29171488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Post-stroke cognitive impairment and the possibility of treatment with cellex].
    Kulesh AA; Shestakov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):38-42. PubMed ID: 27240179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Restoring of the speech functions in patients with aphasia in the early rehabilitation period of ischemic stroke].
    Kotov SV; Belova YA; Shcherbakova MM; Chervinskaya AD; Isakova EV; Volchenkova TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):38-41. PubMed ID: 28374691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke].
    Skorokhodov AP; Dudina AA; Kolesnikova EA; Koron AE; Kobantsev IuA; Sedova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():52-6. PubMed ID: 18193579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
    Strelnikova IA; Svetkina AA; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of GABA
    Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
    Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke.
    Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG
    J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined neuroprotection in the treatment of post-stroke aphasia].
    Safronova MN; Kovalenko AV; Mizurkina OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):20-26. PubMed ID: 31464285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.